Mary A Peters

Title: The Innovative Journey of Mary A. Peters

Introduction

Mary A. Peters is a prominent inventor based in Boulder, Colorado, with a recognized contribution to the field of biotechnology. With three patents to her name, she has demonstrated a commitment to innovation that enhances our understanding and manipulation of human biology. Her work focuses on the manufacture and expression of large structural genes, leading to significant advancements in biomedical applications.

Latest Patents

Among her most notable patents, Mary A. Peters has developed methods for the manufacture and expression of large structural genes. These patents describe her innovative techniques for preparing and expressing manufactured genes that direct the synthesis of human immune interferons, leukocyte interferons, and other biologically active protein products. These engineered proteins differ from their naturally occurring counterparts in terms of amino acid identity, positioning, and various biological and pharmacological properties, yet they retain substantial biological efficacy. This innovation has potential applications in therapeutic settings, significantly impacting the field of medicine.

Career Highlights

Mary A. Peters is currently affiliated with Intermune, Inc., a company dedicated to developing and delivering innovative therapies for serious diseases. Throughout her career, she has emphasized research and development in the field of biotechnology, particularly in generating novel proteins that can be pivotal in disease treatment and understanding immune responses.

Collaborations

During her work, Mary has collaborated with notable professionals in the field, including Norman K. Alton and Yitzhak Stabinsky. These collaborations have enhanced her research capabilities and contributed to the successful innovation of biopharmaceutical products.

Conclusion

Mary A. Peters exemplifies the spirit of innovation through her dedication to advancing biotechnology. Her pioneering work on large structural genes has opened new pathways for research and therapeutic applications, showcasing the vital role inventors play in shaping the future of medicine. As she continues her impactful work at Intermune, her contributions will undoubtedly pave the way for future advancements in the field.